Authors:
XUE YF
BJORQUIST P
INGHARDT T
LINSCHOTEN M
MUSIL D
SJOLIN L
DEINUM J
Citation: Yf. Xue et al., INTERFERING WITH THE INHIBITORY MECHANISM OF SERPINS - CRYSTAL-STRUCTURE OF A COMPLEX FORMED BETWEEN CLEAVED PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 AND A REACTIVE-CENTER LOOP PEPTIDE, Structure, 6(5), 1998, pp. 627-636
Authors:
SARTIPY P
BJORQUIST P
CAMEJO G
HURTCAMEJO E
Citation: P. Sartipy et al., STUDIES ON THE INTERACTION OF SECRETORY PHOSPHOLIPASE A(2) TYPE-II (SPLA(2)) AND SPLA(2)-MODIFIED LOW-DENSITY LIPOPROTEINS WITH GLYCOSAMINOGLYCANS, Circulation, 98(17), 1998, pp. 1649-1649
Authors:
BJORQUIST P
EHNEBOM J
INGHARDT T
HANSSON L
LINDBERG M
LINSCHOTEN M
STROMQVIST M
DEINUM J
Citation: P. Bjorquist et al., IDENTIFICATION OF THE BINDING-SITE FOR A LOW-MOLECULAR-WEIGHT INHIBITOR OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 BY SITE-DIRECTED MUTAGENESIS, Biochemistry, 37(5), 1998, pp. 1227-1234
Citation: J. Ehnebom et al., COMPARISON OF CHROMOGENIC SUBSTRATES FOR TISSUE-PLASMINOGEN ACTIVATORAND THE EFFECTS ON THE STABILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1, FIBRINOLYSIS & PROTEOLYSIS, 11(5-6), 1997, pp. 287-293
Authors:
BJORQUIST P
EHNEBOM J
INGHARDT T
DEINUM J
Citation: P. Bjorquist et al., EPITOPES ON PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IMPORTANT FOR BINDING TO TISSUE-PLASMINOGEN ACTIVATOR, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1341(1), 1997, pp. 87-98
Citation: P. Bjorquist et S. Bostrom, DETERMINATION OF THE KINETIC CONSTANTS OF TISSUE FACTOR FACTOR-VII FACTOR VIIIA AND ANTITHROMBIN HEPARIN USING SURFACE-PLASMON RESONANCE/, Thrombosis research, 85(3), 1997, pp. 225-236
Authors:
STROMQVIST M
KARLSSON KE
BJORQUIST P
ANDERSSON JO
BYSTROM M
HANSSON L
JOHANSSON T
DEINUM J
Citation: M. Stromqvist et al., CHARACTERIZATION OF THE COMPLEX OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR BY MASS-SPECTROMETRY AND SIZE-EXCLUSION CHROMATOGRAPHY, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1295(1), 1996, pp. 103-109
Authors:
BJORQUIST P
DEINUM J
TAURE K
WESTERLUND C
OSTLUNDLINDQVIST AM
Citation: P. Bjorquist et al., CHARACTERIZATION OF NOVEL INDENOINDOLES .1. REDOX-RECYCLING WITH ASCORBATE, Biochemical pharmacology, 51(10), 1996, pp. 1403-1410
Authors:
BJORQUIST P
EHNEBOM J
KRISTIANSEN C
DEINUM J
Citation: P. Bjorquist et al., INFLUENCE OF THE DETERGENT TWEEN 80 ON THE ACTIVITY OF PAI-1 AND PROTECTION BY VITRONECTIN, Thrombosis and haemostasis, 73(6), 1995, pp. 1009-1009
Citation: J. Ehnebom et al., STABILIZATION OF PAI-1 BY AN ANTIBODY SPECIFIC FOR ACTIVE PAI-1, COMPARED TO THE EFFECT OF VITRONECTIN, Thrombosis and haemostasis, 73(6), 1995, pp. 1009-1009
Authors:
PUSA S
KRISTIANSEN C
EHNEBOM J
BJORQUIST P
DEINUM J
Citation: S. Pusa et al., DESTABILIZATION OF PAI-1 BY CHROMOGENIC TPA SUBSTRATES AND PROTECTIONBY VITRONECTIN, Thrombosis and haemostasis, 73(6), 1995, pp. 1010-1010
Citation: S. Bostrom et P. Bjorquist, DETERMINATION OF THE KINETIC CONSTANTS FOR THE INTERACTION OF FACTOR-VII VIIA AND TISSUE FACTOR (TF) USING 2 DIFFERENT METHODS/, Thrombosis and haemostasis, 73(6), 1995, pp. 1234-1234
Authors:
ABRAHAMSSON T
BJORQUIST P
DEINUM J
EHNEBOM J
HULANDER M
LEGNEHED A
MATSSON C
NERME V
WESTINERIKSSON A
AKERBLOM B
Citation: T. Abrahamsson et al., AN ANTIBODY FRAGMENT AGAINST PAI-1 INHIBITS PAI-1 ACTIVITY AND STIMULATES FIBRINOLYSIS IN-VITRO AND IN-VIVO, Fibrinolysis, 8, 1994, pp. 55-56
Authors:
BJORQUIST P
BROHLIN M
EHNEBOM J
ERICSSON M
KRISTIANSEN C
POHL G
DEINUM J
Citation: P. Bjorquist et al., PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 INTERACTS EXCLUSIVELY WITH THEPROTEINASE DOMAIN OF TISSUE-PLASMINOGEN ACTIVATOR, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1209(2), 1994, pp. 191-202
Citation: P. Bjorquist et al., MEASUREMENT OF SUPEROXIDE ANION PRODUCTION USING MAXIMAL RATE OF CYTOCHROME(III)-C REDUCTION IN PHORBOL ESTER-STIMULATED NEUTROPHILS, IMMOBILIZED TO MICROTITER PLATES, Biochemical pharmacology, 48(10), 1994, pp. 1967-1972